Literature DB >> 28413509

Effects of siRNA-mediated suppression of HPV-11 L1 expression on the proliferation and apoptosis of vaginal epithelial cells.

Juan Zeng1, Shumei Yang1, Xiaorui Wang2, Yan Gao3, Mei Zhang1.   

Abstract

The aim of the present study was to investigate the effects of human papillomavirus (HPV) infection on the gynecological disease of vaginitis and to demonstrate how the small interfering RNA (siRNA) method may be used for HPV prevention in the clinic. Human vaginal epithelial cells were transfected with HPV-11 L1 expression vector and siRNA-HPV-11 L1 vectors and a control group was transfected with scrambled siRNA. Cell proliferation in each group was analyzed using the MTT assay and the expression of apoptosis-associated proteins was measured by western blot analysis. Compared with the control group, HPV-11 L1 mRNA and protein levels were significantly increased following transfection with the HPV-11 L1 expression vector in cells (P<0.05), but this result was significantly reversed by silencing of HPV-11 L1 (P<0.05). In addition, cell proliferation in the HPV-11 group was lower than that in the control group; however, cell proliferation was significantly increased in cells transfected with silenced L1 compared with that in the control group (P<0.05). Furthermore, silencing of HPV-11 L1 significantly decreased caspase-3 and caspase-9 expressions in cells, whereas the expression was increased in the HPV-11 L1 group (P<0.05). The present study suggested that siRNA-mediated silencing of HPV-11 L1 may have potential therapeutic applications for treating gynecological diseases associated with HPV-11 infection.

Entities:  

Keywords:  human papillomavirus; small interfering RNA; vaginal epithelial cells; vaginitis

Year:  2017        PMID: 28413509      PMCID: PMC5377549          DOI: 10.3892/etm.2017.4120

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Development of automated paper-based devices for sequential multistep sandwich enzyme-linked immunosorbent assays using inkjet printing.

Authors:  Amara Apilux; Yoshiaki Ukita; Miyuki Chikae; Orawon Chailapakul; Yuzuru Takamura
Journal:  Lab Chip       Date:  2012-11-19       Impact factor: 6.799

3.  An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.

Authors:  Gweneth B Lazenby; Peyton T Taylor; Barbara S Badman; Emil McHaki; Jeffrey E Korte; David E Soper; Jennifer Young Pierce
Journal:  Clin Ther       Date:  2014-01-01       Impact factor: 3.393

4.  HPV-16 E6/7 immortalization sensitizes human keratinocytes to ultraviolet B by altering the pathway from caspase-8 to caspase-9-dependent apoptosis.

Authors:  Cynthia M Simbulan-Rosenthal; Alfredo Velena; Timothy Veldman; Richard Schlegel; Dean S Rosenthal
Journal:  J Biol Chem       Date:  2002-04-25       Impact factor: 5.157

5.  Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis.

Authors:  Bryan T Mayer; Sujatha Srinivasan; Tina L Fiedler; Jeanne M Marrazzo; David N Fredricks; Joshua T Schiffer
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

Review 6.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

7.  High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer.

Authors:  Louise T Thomsen; Kirsten Frederiksen; Christian Munk; Jette Junge; Philip E Castle; Thomas Iftner; Susanne K Kjaer
Journal:  Obstet Gynecol       Date:  2014-01       Impact factor: 7.661

8.  Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

Authors:  Marij J P Welters; Gemma G Kenter; Sytse J Piersma; Annelies P G Vloon; Margriet J G Löwik; Dorien M A Berends-van der Meer; Jan W Drijfhout; A Rob P M Valentijn; Amon R Wafelman; Jaap Oostendorp; Gert Jan Fleuren; Rienk Offringa; Cornelis J M Melief; Sjoerd H van der Burg
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

9.  Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women.

Authors:  Peter Hillemanns; Matthias Jentschke; Thomas G Evans; Philipp Soergel; Ralf Hass
Journal:  Arch Gynecol Obstet       Date:  2013-12-18       Impact factor: 2.344

10.  Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.

Authors:  Joanne Lester; Gaurav Pahouja; Barbara Andersen; Maryam Lustberg
Journal:  J Pers Med       Date:  2015-03-25
View more
  1 in total

1.  In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.

Authors:  Sherif Aly El-Kafrawy; Sayed Sartaj Sohrab; Zeenat Mirza; Ahmed M Hassan; Fatima Alsaqaf; Esam Ibraheem Azhar
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.